|
|
|
|
|
|
|
|
|
|
"STRIDE is a randomized, double-blind, controlled, multi-center Phase III study designed to determine if Stimuvax can extend progression free survival in patients treated with hormonal therapy who have inoperable, locally advanced, recurrent or metastatic breast cancer."
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.